S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Artelo Biosciences (ARTL) News Today

$1.32
-0.14 (-9.62%)
(As of 04/17/2024 ET)
SourceHeadline
benzinga.com logoRecap: Artelo Biosciences Q4 Earnings
benzinga.com - March 25 at 1:13 PM
msn.com logoArtelo Biosciences GAAP EPS of -$3.14 misses by $0.58
msn.com - March 25 at 1:13 PM
globenewswire.com logoArtelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
globenewswire.com - March 25 at 8:00 AM
globenewswire.com logoArtelo Biosciences Selected as a Finalist in Johnson & Johnson's Innovation Challenge
globenewswire.com - March 12 at 9:15 AM
finanznachrichten.de logoArtelo Biosciences, Inc.: Artelo Biosciences to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20th
finanznachrichten.de - February 15 at 10:34 AM
finance.yahoo.com logoArtelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12
finance.yahoo.com - January 8 at 3:07 PM
finance.yahoo.com logoArtelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
finance.yahoo.com - December 5 at 9:22 AM
markets.businessinsider.com logoPromising Developments in Artelo Biosciences’ Cancer Therapies Drive Buy Rating Recommendation
markets.businessinsider.com - November 16 at 1:30 PM
msn.com logoArtelo Biosciences GAAP EPS of -$0.83 misses by $0.18
msn.com - November 13 at 3:50 PM
finance.yahoo.com logoArtelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - November 13 at 10:11 AM
morningstar.com logoArtelo Biosciences Inc ARTL
morningstar.com - November 7 at 11:39 PM
finance.yahoo.com logoArtelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023
finance.yahoo.com - November 2 at 9:23 AM
finance.yahoo.com logoArtelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13th
finance.yahoo.com - September 5 at 11:57 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Larimar Therapeutics (LRMR), Artelo Biosciences (ARTL) and Unity Biotechnology (UBX)
markets.businessinsider.com - August 11 at 4:35 PM
markets.businessinsider.com logoArtelo Biosciences (ARTL) Receives a Buy from Ladenburg Thalmann & Co.
markets.businessinsider.com - June 28 at 9:56 AM
msn.com logoArtelo Unvails New Data On ART26.12 Demonstrating Positive Effects In Multiple Models Of Neuropathic Pain
msn.com - June 27 at 12:41 PM
finance.yahoo.com logoArtelo Biosciences Announces Important New Data on ART26.12 Demonstrating Positive Effects in Multiple Models of Neuropathic Pain at the 33rd Annual International Cannabinoid Research Society Symposium
finance.yahoo.com - June 27 at 12:41 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Artelo Biosciences (ARTL), Iterum Therapeutics (ITRM) and TScan Therapeutics (TCRX)
markets.businessinsider.com - May 18 at 8:34 AM
msn.com logoArtelo Biosciences: Q1 Earnings Insights
msn.com - May 11 at 7:26 PM
finance.yahoo.com logoArtelo Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - May 11 at 9:26 AM
finance.yahoo.com logoArtelo Biosciences Initiates the Phase 2a Portion of its CAReS Trial EvaluatingART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
finance.yahoo.com - April 25 at 9:59 AM
markets.businessinsider.com logoArtelo Biosciences (ARTL) Gets a Buy from Maxim Group
markets.businessinsider.com - April 4 at 10:22 AM
markets.businessinsider.com logoArtelo Biosciences (ARTL) Gets a Buy from Ladenburg Thalmann & Co.
markets.businessinsider.com - April 3 at 8:52 AM
seekingalpha.com logoArtelo Biosciences GAAP EPS of -$3.56
seekingalpha.com - April 2 at 2:33 PM
finance.yahoo.com logoArtelo Biosciences to Present at MicroCap Rodeo’s Annual Winter Wonderland – Best Ideas Virtual Investor Conference on February 22, 2023
finance.yahoo.com - February 15 at 10:23 AM
finance.yahoo.com logoArtelo Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - November 8 at 11:40 AM
finance.yahoo.com logoArtelo Biosciences to Present at The LD Micro Main Event XV
finance.yahoo.com - October 18 at 12:49 PM
seekingalpha.com logoARTL Artelo Biosciences, Inc.
seekingalpha.com - October 11 at 1:29 PM
finance.yahoo.com logoArtelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th
finance.yahoo.com - September 22 at 10:27 AM
finance.yahoo.com logoArtelo Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference
finance.yahoo.com - September 7 at 11:20 AM
morningstar.com logoThinking about buying stock in Bed Bath & Beyond, Chembio Diagnostics, Giga Media, Artelo Biosciences, or SNDL?
morningstar.com - August 17 at 11:05 PM
msn.com logoU.S. Stocks Open Lower; Nasdaq Down 150 Points
msn.com - August 17 at 6:05 PM
markets.businessinsider.com logoNasdaq Falls 75 Points; Ventyx Biosciences Shares Spike Higher
markets.businessinsider.com - August 16 at 3:50 PM
seekingalpha.com logoArtelo jumps 21% as publication highlights pre-clinical data on drug platform
seekingalpha.com - August 16 at 3:50 PM
finance.yahoo.com logoArtelo Biosciences Reports Positive Pre-Clinical Results with its Novel Inhibitor to Fatty Acid Binding Protein 5
finance.yahoo.com - August 16 at 10:50 AM
marketbeat.com logoHC Wainwright Reaffirms "Buy" Rating for Artelo Biosciences (NASDAQ:ARTL)
marketbeat.com - August 12 at 8:32 AM
marketbeat.com logo
marketbeat.com - August 10 at 3:13 PM
marketbeat.com logo
marketbeat.com - August 10 at 3:04 PM
marketbeat.com logo
marketbeat.com - August 10 at 2:41 PM
finance.yahoo.com logoArtelo Biosciences, Inc. (ARTL)
finance.yahoo.com - August 6 at 12:18 AM
msn.com logoArtelo Biosciences Reveals Positive Pre-Clinical Results Of ART26.12, A Novel FABP5 Inhibitor, In Alleviating Chemotherapy-Induced Pain
msn.com - June 27 at 3:57 PM
finance.yahoo.com logoArtelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced Pain
finance.yahoo.com - June 27 at 9:55 AM
finance.yahoo.com logoArtelo Biosciences Selected for Oral Presentation at the 32nd Annual ICRS Symposium in Galway, Ireland
finance.yahoo.com - June 24 at 6:23 PM
morningstar.com logoArtelo Biosciences Inc - Stock News
morningstar.com - June 3 at 8:32 AM
finanznachrichten.de logoArtelo Biosciences, Inc.: Artelo Biosciences to Present at MicroCap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th
finanznachrichten.de - May 14 at 11:08 PM
stockhouse.com logoArtelo Biosciences to Present at MicroCap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th
stockhouse.com - May 13 at 5:10 PM
yahoo.com logoArtelo Biosciences to Present at Investor Summit Group's Q2 In-Person Conference in New York
yahoo.com - April 25 at 8:28 AM
seekingalpha.com logoArtelo Biosciences stock soars 40% on pre-clinical data for ART27.13 in cancer-related muscle degeneration
seekingalpha.com - April 13 at 9:54 AM
finance.yahoo.com logoArtelo Biosciences Reports Positive Pre-clinical Results for Lead Program in Cancer-Related Cachexia
finance.yahoo.com - April 13 at 9:54 AM
finance.yahoo.com logoArtelo Expands Collaboration with Trinity College Dublin to Investigate Cellular Biology of Fatty Acid Binding Protein (FABP) Inhibition In Cancer
finance.yahoo.com - March 28 at 6:24 PM
Get Artelo Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARTL and its competitors with MarketBeat's FREE daily newsletter.

Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

ARTL Media Mentions By Week

ARTL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARTL
News Sentiment

1.00

0.38

Average
Medical
News Sentiment

ARTL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARTL Articles
This Week

0

0

ARTL Articles
Average Week

Get Artelo Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARTL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ARTL) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners